Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Field Trip to Open Health Centre in Atlanta

Stockhouse Editorial
9 Comments| January 26, 2021

{{labelSign}}  Favorites
{{errorMessage}}

A leader in the development and delivery of psychedelic therapies, Field Trip Health Ltd. (CSE: FTRP, OTCBB: FTRPF, Forum) announced on Tuesday that it is opening its fifth location in the United States in the city of Atlanta, GA. One of many locations that Field Trip is planning to open in 2021, the Atlanta spot is located in the Glenwood Park neighborhood. This is the first Field Trip Health center to open this year, following the opening of Toronto, New York, Los Angeles and Chicago in 2020.

For more on this location, click here.

In response to significant interest from people and medical professionals in Canada, FTRP had been selected as a trial location for a MAPS-sponsored study on the safety, feasibility and preliminary outcomes of MDMA-assisted therapy to treat eating disorders, including Anorexia Nervosa, a mental health condition and eating disorder. Field Trip’s Toronto location will be used as the trial site for the Health Canada-approved Anorexia Nervosa arm of the Eating Disorder Study.


FULL DISCLOSURE: Field Trip Health Ltd. is a client of Stockhouse Publishing.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company